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ABSTRACT
Objective: To determine the predictors of CD4+ lymphocyte count among pregnant women
in Dar es Salaam, Tanzania.
Methods: Between 04/1995 and 03/1997, HIV-seropositive (n=1,027) and HIV- seronegative
(n=280) pregnant women were interviewed to obtain socio-demographic characteristics.
Later, blood  samples was collected for determination of T-lymphocyte subsets and other
haematological indices.
Results: CD4+ lymphocyte count was significantly higher among HlV-seronegative women
(mean=770 cells/mm3, standard deviation (SD)=232 cells/mm3) than HIV-seropositive women
(mean=422 cells/mm3, SD=205 cells/mm3). Most HIV-seropositive women were asymptomatic,
in WHO clinical stage 1 (84.3%). Among HIV-seropositive women, total white blood count
(WBC) and erythrocyte sedimentation rate (ESR) remained significantly correlated with
CD4+ after adjusting for other predictors in multivariate analyses. For women of average
age 25 years, the CD4+ lymphocyte count increased by about 16 cells/mm3 for each increment
of 1000 WBC cells/mm3, while each 10 mm/hr increase in ESR was associated with a
reduction of CD4+ lymphocyte count of about 8 cells/mm3.
Conclusion: These results show that simple and inexpensive haematological indices cannot
be recommended for use as alternative measures of HIV-related immunosuppression in this
population of mainly asymptomatic women.
INTRODUCTION
The T-lymphocyte cell surface glycoprotein cluster
determinant 4 (CD4) has been studied extensively because
it is the major receptor for HIV(1). Repeated or persistent
exposure of the immune system to viral antigen leads to
general impairment of functional capability of immune
competent cells, immune system dysfunction and an
abnormal programme of cell death(2). Consequently, there
is progressive reduction in the number of CD4+
lymphocytes in HIV-infected individuals.
Although the CD4+ lymphocyte count provides
important prognostic information, determination of
lymphocyte subsets requires resources and technical
expertise not routinely available in most developing
countries. This is particularly true in most sub-Saharan
African countries where approximately 67% of the world’s
HIV-infected population reside(3). In these countries,
affordable alternative markers of immunosuppression in
HIV-infected patients would be valuable. Such markers
would improve the ability of health care workers to monitor
disease progression and help in clinical staging of HIV
disease. Total lymphocyte count has been found to be
highly correlated with CD4+ lymphocyte count(4), and has
been shown to be a prognostic indicator of both short-term
and long-term survival(5,6). As a result, the WHO advocates
the use of total lymphocyte count as an alternative to CD4+
lymphocyte count when the latter is not available(7). Other
simple blood indices, such as low red blood cell count, low
haematocrit or haemoglobin, and elevated erythrocyte
sedimentation rate (ESR) have been identified to be
predictors of decreasing CD4+ lymphocyte counts(8-11).
Other studies have evaluated the role of potential co-
factors for progression to AIDS or AIDS-related complex
among HIV-infected persons. These factors include socio-
demographic characteristics such as age(11), cigarette
smoking(12,13), and dietary intake of key nutrients(14-
16). The majority of these studies were conducted in
developed countries and may not be generalisable to
developing countries. Hence, there is a critical need for
data from less developed countries, such as Tanzania,
where more than 1.5 million people are estimated to have
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been infected by the HIV(17). Furthermore, there is limited
data to show the association between potential co-factors
and CD4+ lymphocyte count among pregnant women.
Thus, we studied predictors of CD4+ Iymphocyte count
among HIV-seropositive and HIV-seronegative pregnant
women in Dar es Salaam Tanzania, and assessed the
association between CD4+ lymphocyte count and clinical
stages of HIV/AIDS disease. We also examined samples
from comparable HlV-seronegative women to describe
the distribution of T-lymphocyte subsets among healthy
pregnant women in the study population.
MATERIALS AND METHODS
Recruitment and study procedures: Data used in this report
were collected from HIV-seronegative pregnant women receiving
antenatal care in Dar es Salaam, Tanzania. HIV-seropositive
women were participating in an ongoing randomised, controlled,
double-blind clinical trial designed to assess the effect of
supplementation of vitamins on perinatal transmission of HIV
and progression of HIV disease. HIV-seronegative women were
participating, as controls, in a sub-study aimed at assessing the
psycho-social impact of HIV-seropositivity among women
enrolled in the trial. Recruitment of HIV-seropositive women
was done between April 1995 and March 1997 at four main
antenatal clinics serving the three administrative districts of Dar
es Salaam city. During the study period, all pregnant women
between 12-27 weeks of gestation receiving antenatal care at
selected clinics received a brief description of the study procedures
and HIV pre-test counseling. Blood for HIV testing was collected
from women who gave verbal consent (n=13,867). All women
were requested to return to the clinics within one to two weeks
for HIV post-test counselling. Out of 1,802 women who were
HIV-seropositive, 1,085 (60%) returned for their results and
consented to participate in the trial. Two hundred and eighty
HIV-seronegative women were sampled from women who
returned for HIV results at one of the clinics (Mwananyamala)
and consented to be followed in the psycho-social sub-study.
After enrollment, all HIV-seropositive women were
transferred to the study clinic at Muhimbili Medical Centre
(MMC) where they were randomised and followed up to the time
of delivery and for at least two years thereafter. Similar follow  up
was done among HlV-seronegative women at the Mwananyamala
clinic. Standard antenatal and postnatal care and counseling
were provided during the follow up period. At baseline, all
women were interviewed by trained female nurses using
standardised questionnaires to obtain information about
sociodemographic characteristics, complete birth histories, sexual
practices, and contraceptive use histories.
After interview, blood was collected in EDTA vacutainer
tubes and transported to the laboratory within three to four  hours
for determination of T-lymphocyte subsets. Among HIV-
seropositive women, other haematological indices were estimated
from the blood samples. To assess within-person variability of
CD4+ lymphocyte measurements, we collected duplicate blood
samples from 79 women. To ensure that technicians who
conducted the tests could not identify which samples were from
the same woman, the second sample of blood from each woman
was labeled using a different serial number and presented to the
laboratory with other samples. The study protocol was approved
by the Ethical Committee of Tanzania National AIDS Control
Programme, Research and Publications Committee of Muhimbili
University College of Health Sciences, and the Institutional
Review Board of the Harvard School of Public Health.
Laboratory methods: Blood for HIV testing and T-
lymphocyte subsets was processed in the Department of
Microbiology and Immunology at MMC. HIV infection was
diagnosed using an enzyme linked immunosorbent assay (ELISA)
(Murex Biotech Ltd, Dartford, UK) and reactive samples were
confirmed by Western blot (Bio-Rad Laboratories Ltd,
Hertfordshire, UK) according to the World Health Organisation
(WHO) criteria(18). The FACScount system (Becton Dickinson
Systems San Jose, CA) was used for enumeration of the T-
lymphocyte subsets. Unlysed whole blood was mixed, reverse
pipetted and run on the FACScount instrument and analysed
according to the manufacturer’s recommendation to obtain
absolute counts of CD3+, CD4+ and CD8+ lymphocytes. Blood
samples rejected by the FACScount system were analysed by
using the FACScan cytometer (Becton Dickinson
Immunocytometry Systems, San Jose, CA). The percentages of
CD3+, CD4+ and CD8+ lymphocytes obtained from flow
cytometry were multiplied by total Iymphocyte count measured
on whole blood within six hours of collection on a Microdiff 18
Coulter cell counter (Coulter Corporation, Miami, FL) to obtain
absolute counts of CD3+, CD4+ and CD8+ lymphocytes. Both
FACScount and FACScan were serviced regularly by the
manufacturers.
Estimation of haemoglobin and total white blood cells
(WBC) was done by using the CBC5 Coulter counter (Coulter
Corporation, Miami, FL) while WBC differential count was
done manually. ESR was estimated by mixing 750 microlitres of
blood with 250 microlitres of 3.8% disodium citrate in the ESR
tube. The tube was left to stand upright at 90° for one hour and
the results reported in mm/hour. For haematocrit, capillary tubes
loaded with blood were sealed at one end with wax and centrifuged
in a haematocrit centrifuge at 5000 rpm for 15 minutes. Later,
packed cell volume was read on a hematocrit scale and reported
as percentages. Vitamin A and E serum levels were determined
by using high performance liquid chromatography procedures.
Statistical methods: These analyses included the 1029/
1085 (94.8%) HIV-seropositive women and 280 HIV-
seronegative women with baseline CD4+ lymphocyte
measurements. Two HIV-seropositive women with CD4+
lymphocyte count > 1700 cells/mm3 were excluded from the
analyses. All analyses were performed using SAS statistical
software (SAS Institute Inc., Cary, NC, USA). The frequency
distributions of CD4+ lymphocyte count and of all potential
predictors was initially inspected and extreme data values checked.
The maximum likelihood estimates of between- and within-
person variances in the underlying CD4+ lymphocyte count
were obtained from a random effects model as implemented by
SAS PROC MIXED(19). The intraclass correlation coefficient
(ICC) of reliability was obtained by dividing the between-person
variance by the sum of the between- and within-person variances.
The 95% confidence intervals for the ICC was calculated as
given by Hankinson et al(20). The coefficient of variation of
CD4+ lymphocyte count is the ratio of the within-person standard
deviation of the loge CD4+ lymphocyte count, to the sample
mean loge CD4+ lymphocyte count.
The distribution of continuous variables among HIV-
seropositive and HIV-seronegative women was compared by
using the Wilcoxon rank-sum test(21). Age-adjusted Spearman’s
partial correlation coefficients (rs) were used to quantify the
associations between pairs of continuous variables. Later, multiple
linear regression models were fitted to determine haematological
indices which were significant predictors of CD4+ lymphocyte
count among HIV-seropositive women. After identifying the
final model, the distribution of the residuals was inspected and
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tested for normality. Since residuals from all models were not
normal, robust variance estimates were used in all the results
presented. This method gives standard errors for the regression
coefficients that are asymptotically unbiased even if the normality
assumption is violated(19).
Further analyses were done to determine the ability of
haematological indices in the final model to predict CD4+ count.
Initially, predicted CD4+ lymphocyte count for each subject was
calculated from the final regression model equation obtained
when the index subject was excluded from the dataset. To assess
the validity of the regression model for predicting CD4+
lymphocyte count in future patients, a jacknifed correlation
between the observed and predicted CD4+ counts was
calculated(22). Later, CD4+ count was categorised into two
groups (<200 cells/mm3 and > 200 cells/mm3) and we tested the
ability of logistic regression models to identify women with
CD4+ counts < 200 cells/mm3. Using probabilities of CD4+
count < 200 cells/mm3 predicted by the models, we calculated
the sensitivity and specificity of predicting CD4+ count < 200
cells/mm3 at various cut-off points of predicted probabilities.
The receiver operating characteristic (ROC) curve was used to
determine the cut-off point which maximises both sensitivity
and specificity(23), and the area under the ROC curve was used
to calculate the accuracy of the models.
RESULTS
The distribution of baseline socio-demographic
characteristics, HIV clinical stages, haematological indices
and serum nutrients in the study population are presented
in Table 1. The CD4+ lymphocyte count was significantly
higher among HIV-seronegative (mean=770 cells/mm3,
standard deviation (SD)=232 cells/mm3) than HIV-
seropositive women (mean=422 cells/mm3, SD=205 cells/
mm3). Only 131 (12.8%) of HIV-seropositive women and
none of the HIV-seronegative women had CD4+
lymphocyte count below 200 cells/mm3. HIV-seronegative
women had significantly higher CD3+ lymphocyte count
than HIV-seropositive women. However, CD8+
lymphocyte count was significantly higher among HIV-
seropositives (mean=748 cells/mm3, SD=330 cells/mm3)
than among HIV-seronegatives (mean=498 cells/mm3,
SD=211 cells/mm3). HIV-seropositive women were
significantly older than HIV-seronegative women. Most
HIV-seropositive women were asymptomatic, in WHO
clinical stage 1 (84.3%). CD4+ lymphocyte count decreased
significantly with advancing clinical stage of the disease.
Baseline serum vitamin A and E results were available
from 365/1085 (33.6%) HIV-seropositive women. Mean
serum vitamins A and E was 25.9 µg/dl (SD=10.0 µg/dl)
and 9.4 µmol/L (SD=2.4 µmol/L) respectively.
Table 1
Distribution of socio-demograpbie characteristics, haematological indices and serum nutrients among HIV-seropositive and HIV-seronegative
women, Dar es Salaam, Tanzania
Variable HIV-positive HIV-negative P-valuea
(n=1027) (n=280)
Mean(SDb) Median Mean(SDb) Median
Socio-demographic and anthropometric variables
Age(years) 25 (5) 24 23 (5) 21 0.0001
Gestation age at recruitment (weeks) 18 (3) 18 19 (3)  19 0.002
Weight (kg) 57 (9) 56 56 (9) 55 0.01
Height (cm) 156 (6) 155 155 (7) 155 0.51
Mid-upper arm circumference (cm) 23 (3) 23 25 (3)  25 0.04
Body mass index (kg/m2) 24 (3) 23 23 (3) 23 0.01
Hematological indices and serum nutrients
CD4+ count (cells/mm3) 422 (205) 405 770 (232) 715 0.0001
CD4+ count (cells/mm3) by HIV clinical stagesc
HIV Stage 1 428 (204) 410
HIV Stage 2 394 (207) 363
HIV Stage 3 326 (226) 270
CD8+ count (cells/mm3) 748 (330) 680 498 (211) 470 0.0001
CD3+ count (cells/mm3) 1230 (451) 1177 1339 (406) 1293 0.0004
Total white blood cell count (cells/mm3) 5240 (2336) 4600
Total Iymphocyte count (cells/mm3) 1886 (931) 1701
Haemoglobin (g/100 ml) 10 (2) 10
Erythrocyte sedimentation rate (mm/hr) 59 (36) 50
Haematocrit(%) 29 (5) 29
Serum vitamin A (µg/dl)d 26 (10) 25
Serum vitamin E (µmol/L)d 9 (2) 9
aWilcoxon rank-sum test; bSD denotes standard deviation, cBased on WHO HIV clinical staging; dSerum measurements of these nutrients were available from 365 HIV-seropositive women only.
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Table 3
Predictors of CD4+ T-lymphocyte count - results from multiple linear
regression models
Model 1  Model 2
ß P value* ß P value*
Intercept 392.5 389.6
Total white blood cell
count  (per 1000 cells/mm3) 15.9 0.0001 15.2 0.0001
Erythrocyte sedimentation
rate (per 10 mm/hr) -7.7 0.0001 -7.1 0.0001
Age (years)** -7.1 0.0001
Model R2 0.06 0.08
* All p-values are based on robust variance estimates.
** Age was centered around its mean value of 25 years.
the final model after adjusting for other determinants.
Among women of average age, the CD4+ lymphocyte
count increased by about 16 cells/mm3 for each increment
of 1000 WBC cells/mm3, while each l0 mm/hr increase-
in ESR was associated with a reduction of CD4+
Iymphocyte count of about 8 cells/mm3. The jacknifed
correlation between observed CD4+ lymphocyte count
and counts predicted from this model was 0.23. These
results were not significantly changed after adding age in
the model (model 2). However, these models explained
less than 10% of the CD4+ lymphocyte count variance in
this population. Among HIV-seronegative women, none
of the socio-demographic and anthropometric variables
Table 2
Age-adjusted Spearman’s correlation coefficients (rs) between CD4+ lymphocyte count and socio-demographic variables, haematological
indices and serum nutrients among HIV-seropositive and HIV-seronegative women, Dar es Salaam, Tanzania
Predictor HIV-positive (N=1027) HIV-negative (N=280)
rs P-value rs P-value
Socio-demographic/anthropometric variables
Age (years) -0.20 0.0001 -0.09 0.15
Gestation age at recruitment (weeks) 0.001 0.98 0.07 0.26
Weight (kg) 0.03 0.33 0.07 0.22
Height (cm) -0.01 0.79 -0.04 0.51
Mid-upper arm circumference (cm) 0.08 0.01 0.05 0.43
Body mass index (kg/m2) 0.05 0.13 0.11 0.07
Haematological indices/serum nutrients
CD8+ count (cells/mm3) 0.28 0.0001 0.53 0.0001
CD3+ count (cells/mm3) 0.66 0.0001 0.87 0.0001
Total Iymphocyte count (cells/mm3) 0.18 0.0001
Haemoglobin level (g/100ml) 0.10 0.001
Haematocrit (%) 0.10 0.001
Total white blood cells (cells/mm3) 0.22 0.0001
Erythrocyte sedimentation rate (mm/hr) -0.17 0.0001
Serum vitamin A (µg/dl)* 0.08 0.12
Serum vitamin E (µmol/L)* 0.08 0.14
* Serum measurements of these nutrients were available from 365 HIV-seropositive women only.
The CD4+ lymphocyte count reliability coefficient
was 0.77 (95% confidence interval (CI) = 0.67-0.85) and
the coefficient of variation (CV) was 24% (95% CI = 20-
29%). Table 2 shows age-adjusted correlations between
CD4+ lymphocyte count and continuous predictors among
HIV-seropositive and HIV-seronegative women. Of all
socio-demographic and anthropometric variables
presented, age had the strongest correlation with CD4+
lymphocyte count among HIV-seropositive women (rs =
-0.20, p = 0.0001). Mid-upper arm circumference had a
weak but significant positive correlation with CD4+
lymphocyte count among HIV-seropositive women (rs =
0.08, p = 0.01). Among HIV-seronegative women, none of
the socio-demographic and anthropometric variables were
significantly associated with CD4+ lymphocyte count.
All other T-lymphocyte subsets and haematological indices
measured in this study were significantly correlated with
CD4+ lymphocyte count among HIV-seropositive women.
The strongest association was observed between CD4+
lymphocyte count with CD3+ (rs = 0.66, p = 0.0001),
CD8+ (rs = 0.28, p = 0.0001) lymphocyte counts, and total
white blood cell count (rs = 0.22, p = 0.0001). Similarly,
CD3+ (rs = 0.87, p =0.0001) and CD8+ (rs = 0.53, p =
0.0001) lymphocyte count were significantly correlated
with CD4+ lymphocyte count among HIV-seronegative
women. Baseline serum vitamins A and E were not
correlated with CD4+ lymphocyte count among HIV-
seropositive women.
Results from multiple linear regression models are
presented in Table 3. As shown in Model 1, total WBC and
ESR were the only haematological indices that were
significantly correlated with CD4+ lymphocyte count in
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were significantly correlated with CD4+ lymphocyte count
in multivariate analyses.
The sensitivity and specificity of predicting CD4+
lymphocyte count below 200 cells/mm3 using model
probabilities at various cut-off points was calculated by
using the ROC curve. The proportion of the area of the
entire graph that lies beneath the curve was 0.63. The
sensitivity and specificity was maximised when the models
predicted probabilities was greater than 0.127. If all patients
with this predicted probabilities were classified as having
CD4+ lymphocyte counts below 200 cells/mm3, the
sensitivity and specificity of this procedure was 60% and
64% respectively. Increasing the probability cut-off point
was associated with increasing sensitivity and decreasing
specificity.
DISCUSSION
The reliability of CD4+ lymphocyte measurements
was high indicating that laboratory error was not a major
source of misclassification in this study. The distribution
of T-lymphocyte subsets among healthy HlV-seronegative
pregnant women were similar to those reported by other
studies in both developing and industrialised countries
(mean 736 - 828 cells/mm3)(24-26). Several studies have
observed a reduction in CD4+ lymphocyte count during
pregnancy among HIV-seropositive women(24-27) and a
return to normal levels at time of delivery(25,27) or during
the first few weeks after delivery(24,26). Potential
mechanisms to explain these changes include pregnancy
induced leukocytosis that leads to increased WBC count
and decreased percentage of lymphocytes(28),
haemodilution resulting from increased blood volume(24),
re-distribution of CD4+ cells in tissues and lymph
nodes(27), and hormonal changes associated with
pregnancy(29). These changes complicate the
interpretation of T-lymphocyte subset results in studies
involving pregnant women. The findings of this study
provide information about the distribution of T-lymphocyte
subsets among both HIV-seropositive and HIV-
seronegative pregnant women. The results from healthy
HIV-seronegative women provide an important source of
information which can be used as reference values for
pregnant women in Tanzania.
Most HIV-seropositive women in this study were
asymptomatic in the WHO clinical stage 1. The distribution
of T-lymphocyte subsets observed in this population was
comparable to those reported in other studies involving
asymptomatic HIV-seropositive pregnant women(26).
CD4+ lymphocyte count of less than 200 cells/mm3 is
considered by the Centers for Diseases Control and
Prevention (CDC) as an AIDS-defining laboratory
criterion(30). Although a substantial proportion of HIV-
seropositive women in this study(12.8%) met this
laboratory criterion, most of these women were healthy
and had no symptoms suggestive of AIDS. This suggests
that laboratory parameters alone may not be adequate to
define clinical stages of HIV disease among pregnant
women in this population.
Although CD4+ lymphocyte count is the most used
index of the level of cell mediated immunity in HIV-
infected patients, it is not readily available in most
developing countries. As a result, numerous simple and
less expensive hematological indices are being considered
as alternative measures of immunosuppression in HIV-
infected people. For example, the cost of full blood count
is about 21% of that of CD4+ lymphocyte count(4).
Several studies have reported on the association between
CD4+ lymphocyte count and other simple haematological
indices(4,5,8,9,10). Most of these studies have reported
poor correlations in asymptomatic patients and much
stronger associations in patients with advanced disease(4).
In this study, we observed weak but significant correlations
between haematological indices and CD4+ lymphocyte
count in univariate analyses. In multivariate analyses,
only total WBC count and ESR remained significant
predictors of CD4+ lymphocyte count. However, WBC
and ESR explained a very small proportion of the variance
of CD4+ lymphocyte measurements, and had unacceptably
low sensitivity and specificity even when the dichotomous
cut-off point was optimised using an ROC curve. Hence,
these simple haematological indices cannot be
recommended for use as markers of cell mediated
immunosuppression among asymptomatic women.
Women’s age and mid-upper arm circumference
(MUAC) were significant predictors of CD4+ lymphocyte
count. The role of age as a predictor of CD4+ lymphocyte
count among adults is uncertain. In normal healthy adults,
an increase in CD4+ lymphocyte count with age has been
reported by some studies(31,32), while other studies have
not observed any association(31). Similar conflicting
results have been reported among HIV-seropositive
populations(33). In this study, CD4+ lymphocyte count
was inversely correlated with age among HIV-seropositive
women. We also observed a weak but significant positive
correlation between CD4+ lymphocyte count and MUAC.
These associations might be confounded by duration of
HIV-infection. Relatively high CD4+ lymphocyte count
among younger women, with presumably more recent
seroconversion, might be due to shorter duration of HIV-
infection. Duration of infection has been shown to be a
major predictor of CD4+ lymphocyte count and disease
progression among HIV infected adults(34). Among HIV-
seronegative women, CD4+ lymphocyte count was not
significantly correlated with age and anthropometric
variables. This suggests that the observed associations
between age and MUAC among HIV-seropositive women
are related to HIV disease.
This study has several limitations. First, the power of
this study to assess predictors of clinical stages of HIV
disease was limited because most women were
asymptomatic in WHO clinical stage 1. Secondly, lack of
information about the duration of infection limits our
ability to adjust for this important predictor of CD4+
lymphocyte count in the analyses presented in this report.
Hence, the observed association between CD4+
lymphocyte count and predictors might be confounded by
duration of HIV disease. Thirdly, physiological changes
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associated with pregnancy were likely to have influenced
the distribution of CD4+ lymphocyte count in this study.
These changes might have affected some of the associations
between potential predictors and CD4+ lymphocyte count.
In conclusion, HIV-seronegative women had
significantly higher CD4+ lymphocytes count than HIV-
seropositive women. Most HIV-seropositive women were
asymptomatic in WHO clinical stage 1, but CD4+ counts
were lower among women with stage 2 and 3 disease.
Women’s age and MUAC were significantly associated
with CD4+ lymphocyte count among HIV-seropositive
women. Results from simple haematological tests were
weakly correlated with CD4+ lymphocyte count in both
univariate and multivariate analysed. Hence, there were
no simple haematological tests which could be
recommended as alternative measures of HIV-related
immunosuppression in this population of mainly
asymptomatic women.
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